Tissue plasminogen activator can improve neurologic outcome after acute ischemic stroke (AIS); however, as an intravenous or catheter-based treatment strategy, it is not suitable for all AIS patients.

Mechanical embolectomy performed with general instead of local anesthesia is associated with worse clinical outcomes and poorer survival, according to an article published online March 25, 2014, ahead ...

Revascularization therapy is pivotal to saving ischemic brain from infarction. Two major randomized trials of intravenous thrombolytic therapy have established clear clinical benefit, especially for ...

Penumbral imaging does not help identify patients who would benefit from endovascular therapy following acute ischemic stroke, according to findings presented February 8, 2013, at the International ...

Each moment we are given holds possibility. Yet, every 40 seconds a person suffers from a stroke, which can take away that promise of possibility. Millions of Americans and their families are affected ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ RDL Radial Access System, the company’s latest ...

Please provide your email address to receive an email when new articles are posted on . Among patients with nonvalvular atrial fibrillation and frailty, rivaroxaban was associated with reduced risk ...

MINNEAPOLIS, MN — A new review based on data from four large contemporary trials of patients with atrial fibrillation (AF) has shed light on the incidence, risk factors, and morbidity of extracranial ...

Thrombectomy and embolectomy are procedures used to treat two different types of blood clots from blood vessels. A thrombectomy is surgery to remove a stationary blood clot from one of your arteries ...